Re-anamnesis as a Mandatory Post-Imaging Diagnostic Node: Clinical Validation of the ISWB Sequential Bayesian Model in Three Neuroradiology Cases with Posterior Gains of 0.84–0.92 and EU AI Act Art. 14 Compliance Mapping

Background: Current AI-assisted radiology workflows lack a formalized mechanism for mandatory post-imaging clinical re-evaluation. The ISWB (Ishikawa-Small- World-Bayesian) model addresses this gap by structuring the diagnostic pathway as a weighted directed acyclic graph G = (V, E, W) with ten sequential nodes (v1-v10). Methods: We applied the ISWB model to three retrospective neuroradiology cases: frontal haematoma (Case 1), meningioma (Case 2), and Denis I vertebral fracture (Case 3). For each case, we computed prior probability P0(H) from epidemiological prevalence and calculated posterior gains Delta-P at each diagnostic node using sequential Bayesian updating. Node v4 (re-anamnesis) was implemented as a mandatory post-imaging step requiring an Independent Clinical Review (ICR >= 90% SLA) before therapeutic decision. Results: Re-anamnesis (v4) produced posterior probability gains of Delta-P = 0.90 (Case 1), Delta-P = 0.84 (Case 2), and Delta-P = 0.92 (Case 3). In Case 3, a single targeted re-anamnesis question yielded 47% of the total information gain achievable by full MRI, demonstrating the high diagnostic efficiency of structured post-imaging clinical review. AI integration at node v3 (compatible with published architectures such as NVIDIA NV-Reason-CT) provided structural pattern recognition without replacing mandatory clinical judgment. Conclusions: The ISWB model provides a validated sequential framework for AI-assisted neuroradiology that formally satisfies EU AI Act Art. 14, paragraph 4(b) requirements for independent clinical judgment prior to acting on AI output. The mandatory re-anamnesis arc (v3->v4) represents a reproducible, quantifiable safety mechanism applicable to clinical AI deployment. Within the HIC/HITL/HOTL taxonomy, ISWB is structurally defined as a Human-in-the- Loop (HITL) architecture, with v4 as the mandatory gate preventing autonomous diagnostic closure.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24210049
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Re-anamnesis as a Mandatory Post-Imaging Diagnostic Node: Clinical Validation of the ISWB Sequential Bayesian Model in Three Neuroradiology Cases with Posterior Gains of 0.84–0.92 and EU AI Act Art. 14 Compliance Mapping

Francesco Matozza, Ernesto Matozza
Zenodo (CERN European Organization for Nuclear Research)
Artificial Intelligence in Healthcare and Education
preprint

Re-anamnesis as a Mandatory Post-Imaging Diagnostic Node: Clinical Validation of the ISWB Sequential Bayesian Model in Three Neuroradiology Cases with Posterior Gains of 0.84–0.92 and EU AI Act Art. 14 Compliance Mapping

Francesco Matozza, Ernesto Matozza
preprint en

Abstract

Background: Current AI-assisted radiology workflows lack a formalized mechanism for mandatory post-imaging clinical re-evaluation. The ISWB (Ishikawa-Small- World-Bayesian) model addresses this gap by structuring the diagnostic pathway as a weighted directed acyclic graph G = (V, E, W) with ten sequential nodes (v1-v10). Methods: We applied the ISWB model to three retrospective neuroradiology cases: frontal haematoma (Case 1), meningioma (Case 2), and Denis I vertebral fracture (Case 3). For each case, we computed prior probability P0(H) from epidemiological prevalence and calculated posterior gains Delta-P at each diagnostic node using sequential Bayesian updating. Node v4 (re-anamnesis) was implemented as a mandatory post-imaging step requiring an Independent Clinical Review (ICR >= 90% SLA) before therapeutic decision. Results: Re-anamnesis (v4) produced posterior probability gains of Delta-P = 0.90 (Case 1), Delta-P = 0.84 (Case 2), and Delta-P = 0.92 (Case 3). In Case 3, a single targeted re-anamnesis question yielded 47% of the total information gain achievable by full MRI, demonstrating the high diagnostic efficiency of structured post-imaging clinical review. AI integration at node v3 (compatible with published architectures such as NVIDIA NV-Reason-CT) provided structural pattern recognition without replacing mandatory clinical judgment. Conclusions: The ISWB model provides a validated sequential framework for AI-assisted neuroradiology that formally satisfies EU AI Act Art. 14, paragraph 4(b) requirements for independent clinical judgment prior to acting on AI output. The mandatory re-anamnesis arc (v3->v4) represents a reproducible, quantifiable safety mechanism applicable to clinical AI deployment. Within the HIC/HITL/HOTL taxonomy, ISWB is structurally defined as a Human-in-the- Loop (HITL) architecture, with v4 as the mandatory gate preventing autonomous diagnostic closure.

Zenodo (CERN European Organization for Nuclear Research)
European Society of Radiology (AT), MNM Consulting (France) (FR)
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon